bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • ImmunityBio Inc. logo

    ImmunityBio Inc.

    IBRX | NASDAQ
    Chart Builder DCF Calculator
    $9.45
    +$1 (+11.83%)
    Sep 22, 2026, 1:59 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $8.85B
    Enterprise Value
    $8.53B
    Beta
    0.14
    Average Volume
    11.28M
    Shares Outstanding (Diluted)
    1.05B
    Shares Change YoY
    18.22%
    Institutional Ownership
    17.40%
    Exchange
    NASDAQ
    ISIN
    US45256X1037

    Price Performance

    Price Change 1M
    10.0%
    Price Change 3M
    15.4%
    Price Change 6M
    4.7%
    Price Change YTD
    318.3%
    Price Change 1Y
    216.5%
    Price Change 3Y
    412.1%
    Price Change 5Y
    -17.6%
    1M CAGR (ann.)
    10.6%
    1Y CAGR (ann.)
    196.5%
    5Y CAGR (ann.)
    -2.9%
    All-Time CAGR
    -11.9%

    Valuation

    PE Ratio
    -8.71
    Forward PE
    116.50
    PEG Ratio
    0.07
    Forward PEG
    0.10
    PS Ratio
    53.38
    Forward PS
    20.00
    PB Ratio
    -8.46
    P/FCF Ratio
    -24.21
    P/Adj. FCF Ratio
    -21.69
    P/OCF Ratio
    -24.85
    EV/Sales
    51.46
    EV/EBIT
    -9.38
    EV/EBITDA
    -9.60
    EV/FCF
    -23.33
    Earnings Yield
    -11.5%
    FCF Yield
    -4.1%
    Adj. FCF Yield
    -4.6%

    Financial Health

    Net Cash
    $318.66M
    Total Debt
    $38.71M
    Cash & Short-Term Investments
    $357.37M
    Total Assets
    $628.5M
    Current Ratio
    5.72
    Quick Ratio
    5.70
    Debt / Equity Ratio
    -0.78
    Debt / EBITDA
    -0.04
    Debt / FCF
    -0.11
    OCF / Debt
    -9.21
    Interest Coverage
    -3.02
    Altman Z-Score
    -0.65
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    94.6%
    Operating Profit Margin
    -151.9%
    EBITDA Margin
    -535.8%
    Net Profit Margin
    -598.6%
    FCF Margin
    -220.5%
    Adj. FCF Margin
    -246.2%
    SBC / Revenue
    25.6%
    SBC Impact (per share)
    -11.6%

    Returns

    Return on Assets
    -157.9%
    Return on Equity
    135.0%
    Return on Invested Capital
    -45.0%
    Return on Capital Employed
    -45.6%
    Return on Tangible Assets
    -160.9%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    554.3%
    Revenue CAGR 5Y
    202.9%
    Revenue CAGR 10Y
    128.9%
    EPS CAGR 3Y
    1.2%
    EPS CAGR 5Y
    7.8%
    EPS CAGR 10Y
    -12.3%
    FCF CAGR 3Y
    7.8%
    FCF CAGR 5Y
    1.1%
    FCF CAGR 10Y
    -18.0%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    5
    EPS Growth Next 3Y
    63.2%
    Revenue Growth Next 3Y
    121.4%
    Earnings Date
    Nov 2, 2026
    EPS Estimate (next Q)
    -$0.08
    EPS Growth Est (next Q)
    14.3%
    Revenue Est (next Q)
    $59.23M
    Revenue Growth Est (next Q)
    84.7%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $12
    Price Target Upside
    42.0%

    Cash Flow

    Operating Cash Flow
    $-356.5M
    Free Cash Flow
    $-365.63M
    Adj. Free Cash Flow
    $-408.11M
    FCF Per Share
    -$0.35
    OCF Per Share
    -$0.34
    OCF/S Ratio
    -215.0%

    Income Statement

    Revenue
    $165.79M
    Gross Profit
    $156.88M
    Operating Income
    $-251.8M
    EBITDA
    $-888.34M
    Net Income
    $-992.36M
    EPS (Diluted)
    -$0.97
    Revenue / Employee
    $240.98K
    Profit / Employee
    $-1.44M
    Employees
    688

    © 2026 bestshares.com. All rights reserved.